The UKCRC Registered Clinical Trials Unit (CTU) Network invites its 48 currently registered clinical trials units to apply for review of their registered status and invites new applications from previously unregistered Units to undergo the Registered Process.

Model Agreements between sponsors and host institutions have been developed to be used without modification since 2006. These commerical contracts have now been revised to take into account the Bribery Act 2010 and definition of 'agent'.

The public are being encouraged to give researchers access to their health records to help provide vital insight into what causes illnesses and the steps that can be taken to develop healthcare that benefits everyone.

Are you interested in applying?

The Government announced today the allocation of £800 million funding to boost research and allow the development of ground breaking medicines, treatments and care for patients.

The Association of Medical Research Charities (AMRC) has appointed as its new Chief Executive. Sharmila Nebhrajani was the unanimous choice.

INVOLVE would like the views of groups and individuals who share their interest in public involvement in research to form their new strategic plan for 2012-2015.

The NCRI and NCRN are looking to recruit patients and members of the public to join the NCRI Clinical Studies Group (CSGs) where new ideas for cancer research are developed.

The National Cancer Research Institute (NCRI) is a 21-member partnership between government, charity and industry that promotes co-operation and collaboration in cancer research, to maximise the benefit to patients and the public.

This is a report of a 'think tank' event jointly organised by the Association of Medical Research Charities (AMRC), the James Lind Alliance (JLA) and INVOLVE, with the support of the UKCRC. It brought together representatives from large and small research funding organisations, research comissioners and other groups and individuals with experience of patient and public involvement in research priority setting and commissioning. The purpose of the meeting was to reflect on progress and to consider the future development of patient and public involvement in research priority setting and commissioning processes.